<DOC>
	<DOCNO>NCT00789022</DOCNO>
	<brief_summary>The goal research check level D-Serine , Glycine , Glutamatergic amino acid , patient First Psychotic Episode ( FPE ) . These patient early stage disease , treat neuroleptic short period time , usually hospitalize first time . The hypothesis research find low level Glycine D-Serine patient . Following Anti-psychotic treatment expect level return norm , correction accompany reduction positive negative symptom . In addition , check D-Serine Glycine level plasma first degree relative patient group healthy subject . The result study might support hypothesis Glutamatergic system involve pathology Schizophrenia 's early stage . In addition , check level Oxytocin Estrogen plasma patient FPE . Our hypothesis find low level Estrogen High level Oxytocin group patient . The result study might support hypothesis Estrogen Oxytocin involve pathology Schizophrenia 's early stage .</brief_summary>
	<brief_title>Glutamatergic Amino Acids Oxytocin Levels Plasma Patients First Psychotic Episode ( FPE ) - Before After Neuroleptic Treatment</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>Subjects 1860 year Clinical Diagnosis Schizophrenia , Schizophreniphorm disorder , Schizoaffective Disorder , Brief esychotic episode two year positive symptom Neuroleptic treatment twe week prior month , six week time . Drug induce psychotic episode</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>First-Psychotic-Episode ( FPE )</keyword>
	<keyword>Glutamatergic system</keyword>
	<keyword>Glycine</keyword>
	<keyword>D-Serine</keyword>
	<keyword>Oxytocin</keyword>
	<keyword>Estrogen</keyword>
</DOC>